US2015232920A1PendingUtilityA1
Detection of antibiotic-resistant microorganisms
Est. expiryDec 21, 2027(~1.4 yrs left)· nominal 20-yr term from priority
C12Q 1/689C12Q 2600/158C12Q 2600/16
66
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Method of detecting methicillin-resistant S. aureus (MRSA) and methicillin-sensitive S. aureus (MSSA) in a nucleic acid coamplification assay. The invention advantageously reduces the incidence of false-positive MRSA determinations in real-time assays by requiring satisfaction of a threshold criterion that excludes certain co-infections from the MRSA determination. The invention further provides for determination of MSSA, even when the MSSA is present in combination with methicillin-resistant coagulase-negative (MR-CoNS) bacteria at high or low levels.
Claims
exact text as granted — not AI-modified1 - 3 . (canceled)
4 . A composition for amplifying a nucleic acid sequence encoding methicillin resistance, comprising:
a first oligonucleotide that has a target-complementary base sequence selected from the group consisting of SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, and SEQ ID NO:9; and a second oligonucleotide that has a target-complementary base sequence consisting of SEQ ID NO:13, optionally including a 5′ sequence that is not complementary to the nucleic acid sequence encoding methicillin resistance.
5 . The composition of claim 4 , wherein only one of the first and second oligonucleotides has a 3′ end that can be extended by a template-dependent DNA polymerase.
6 . The composition of claim 5 , further comprising a detectably labeled hybridization probe.
7 - 53 . (canceled)Join the waitlist — get patent alerts
Track US2015232920A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.